It is now established that NWBIO is close (OK, several weeks) to submitting an application to the MHRA. There will then be a longish period while MHRA goes through its process of reviewing, evaluating, and deciding on the MA for DCVAX-L The regulators at MHRA or anywhere else are not going to use the paper for their decision. However, the shorts, adversarial MMs, and their fudster troops need a publicly posted cover for their attacks and stock during this period. Just like the AF article that was used by Citadel in one of its filings to justify its trading attacks, I believe this article, co-authored and posted as an Editor's Choice by an Associate Editor of SNO, is intended to provide that cover during this period.
Bullish